The Role of Systematic and Targeted Biopsies in Light of Overlap on Magnetic Resonance Imaging Ultrasound Fusion Biopsy

Muthigi, 2017, Current beliefs and practice patterns among urologists regarding prostate magnetic resonance imaging and magnetic resonance-targeted biopsy, Urol Oncol, 35, 32, 10.1016/j.urolonc.2016.08.008 Bjurlin, 2014, Optimization of prostate biopsy: the role of magnetic resonance imaging targeted biopsy in detection, localization and risk assessment, J Urol, 192, 648, 10.1016/j.juro.2014.03.117 Siddiqui, 2015, Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer, JAMA, 313, 390, 10.1001/jama.2014.17942 Filson, 2016, Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: the role of systematic and targeted biopsies, Cancer, 122, 884, 10.1002/cncr.29874 Simsir, 2010, Is it possible to predict sepsis, the most serious complication in prostate biopsy?, Urol Int, 84, 395, 10.1159/000296290 Valerio, 2015, Detection of clinically significant prostate cancer using magnetic resonance imaging-ultrasound fusion targeted biopsy: a systematic review, Eur Urol, 68, 8, 10.1016/j.eururo.2014.10.026 Sonn, 2014, Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen, Eur Urol, 65, 809, 10.1016/j.eururo.2013.03.025 Muthigi, 2017, Missing the mark: prostate cancer upgrading by systematic biopsy over magnetic resonance imaging/transrectal ultrasound fusion biopsy, J Urol, 197, 327, 10.1016/j.juro.2016.08.097 Le, 2015, Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology, Eur Urol, 67, 569, 10.1016/j.eururo.2014.08.079 Truong, 2018, A comprehensive analysis of cribriform morphology on magnetic resonance imaging/ultrasound fusion biopsy correlated with radical prostatectomy specimens, J Urol, 199, 106, 10.1016/j.juro.2017.07.037 Aihara, 1994, Heterogeneity of prostate cancer in radical prostatectomy specimens, Urology, 43, 60, 10.1016/S0090-4295(94)80264-5 Arora, 2004, Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate, Cancer, 100, 2362, 10.1002/cncr.20243 Mesko S, Marks L, Ragab O, et al. Targeted prostate biopsy Gleason score heterogeneity and implications for risk stratification. Am J Clin Oncol. 2016: Epub ahead of print. https://doi.org/10.1097/COC.0000000000000308. Rosenkrantz, 2016, Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR, J Urol, 196, 1613, 10.1016/j.juro.2016.06.079 Halpern, 2017, Indications, utilization and complications following prostate biopsy: New York State analysis, J Urol, 197, 1020, 10.1016/j.juro.2016.11.081 Loeb, 2013, Systematic review of complications of prostate biopsy, Eur Urol, 64, 876, 10.1016/j.eururo.2013.05.049 Mehralivand, 2017, Prospective evaluation of PI-RADS version 2 using the International Society of Urological Pathology prostate cancer grade group system, J Urol, 198, 583, 10.1016/j.juro.2017.03.131 Natarajan, 2011, Clinical application of a 3D ultrasound-guided prostate biopsy system, Urol Oncol, 29, 334, 10.1016/j.urolonc.2011.02.014 Priester, 2017, Magnetic resonance imaging underestimation of prostate cancer geometry: use of patient specific molds to correlate images with whole mount pathology, J Urol, 197, 320, 10.1016/j.juro.2016.07.084